drugset / Trial / NCT05857579

Diamond Bur Microblepharoexfoliation, Intense Pulse Light and Meibomian Gland Expression for Evaporative Dry Eye

NCT05857579 ↗

Completed 70 enrolled University of Seville
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to assess the efficacy and safety of microblepharoeexfoliation (MBE), intense pulse light (IPL) and meibomian gland expression (MGX) combination in patients with meibomian gland dysfunction (MGD). The main question it aims to answer are: * Does MBE-IPL-MGX treatment improve dry eye symptoms? * Does MBE-IPL-MGX treatment improve dry eye signs? Participants were assigned to receive either three sessions of MBE-IPL-MGX treatment and home-based therapy (treatment group) or home-based therapy alone (control group). The investigators will compare both groups to see if MBE-IPL-MGX treatment is superior to home-based therapy.

Timeline

Start
2022-04-01
Primary completion
2022-11-01
Completion
2023-01-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Eyestil synfo Unknown — —

Indications